1. Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States
2. US Food and Drug Administration.Guidance for industry: recommnedations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood specimens from donors of human cells tissues and cellular and tissue‐based products (HCT/Ps).2004.http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm073972.htmAccessed March 18 2021.
3. Food and Drug Administration.Testing human cells tissues and cellular and tissue based product (HCT/P) donors for relevant communicable disease agents and diseases.2021.https://www.fda.gov/vaccines‐blood‐biologics/safety‐availability‐biologics/testing‐human‐cells‐tissues‐and‐cellular‐and‐tissue‐based‐product‐hctp‐donors‐relevant‐communicableAccessed March 18 2021.
4. US Food and Drug Administration.Eligibility determination for donors of human cells tissues and cellular and tissue‐based products; guidance for industry.2007.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/eligibility‐determination‐donors‐human‐cells‐tissues‐and‐cellular‐and‐tissue‐based‐products
5. CDC.Transplant safety/protecting patients/donor screening and testing.2019.https://www.cdc.gov/transplantsafety/protecting‐patient/screening‐testing.htmlAccessed March 18 2021.